Privia Health Group, Inc. (PRVA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

28.90

-0.22

(-0.76%)

At close: 04:00PM EDT

28.90

0.00

(0.00%)

After hours:

04:00PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

Commodity Channel Index

View all chart patterns

Performance Outlook

Previous Close	29.12
Open	29.14
Bid	28.91 x 1200
Ask	29.92 x 1300
Day's Range	28.20 - 29.25
52 Week Range	17.99 - 47.77
Volume	676,681
Avg. Volume	655,570

Market Cap	3.139B
Beta (5Y Monthly)	N/A
PE Ratio (TTM)	N/A
EPS (TTM)	-1.99
Earnings Date	May 12, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	34.82

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for PRVA

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Privia Health Group, Inc.
Analyst Report: Moderna, Inc.Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Rating
Fair Value
Economic Moat
3 days agoMorningstar

All

Simply Wall St.
Even after rising 5.4% this past week, Privia Health Group (NASDAQ:PRVA) shareholders are still down 40% over the past year
Privia Health Group, Inc. ( NASDAQ:PRVA ) shareholders should be happy to see the share price up 22% in the last month...
- Shareholders in Compass Minerals International (NYSE:CMP) are in the red if they invested five years ago
  Simply Wall St.
- American Vanguard's (NYSE:AVD) investors will be pleased with their decent 44% return over the last three years
  Simply Wall St.
GlobeNewswire
Privia Receives HFMA’s MAP Award for High Performance in Revenue Cycle for Seventh Straight Year
ARLINGTON, Va., June 27, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that its network of affiliated medical groups, collectively Privia Medical Group, has been named a recipient of the 2022 MAP Award for High Performance in Revenue Cycle, sponsored by the Healthcare Financial Management Association (HFMA). This is the seventh consecutive year that Privia has been recognized by HFMA for its revenue cycle capabilities and performance. As a national award winner, Pri
Zacks
Privia Health (PRVA) Surges 8.1%: Is This an Indication of Further Gains?
Privia Health (PRVA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.